Atıf Formatları
The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. ŞANLIOĞLU Et Al. , "The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis," World Immune Regulation Meeting-III , Davos, Swaziland, pp.104, 2009

ŞANLIOĞLU, S. Et Al. 2009. The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis. World Immune Regulation Meeting-III , (Davos, Swaziland), 104.

ŞANLIOĞLU, S., Bişgin, A., TERZİOĞLU, M. E., YAZISIZ, V., BALCI, M. K., BAĞCI, H., ... Gorczynski, R.(2009). The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis . World Immune Regulation Meeting-III (pp.104). Davos, Swaziland

ŞANLIOĞLU, SALİH Et Al. "The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis," World Immune Regulation Meeting-III, Davos, Swaziland, 2009

ŞANLIOĞLU, SALİH Et Al. "The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis." World Immune Regulation Meeting-III , Davos, Swaziland, pp.104, 2009

ŞANLIOĞLU, S. Et Al. (2009) . "The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis." World Immune Regulation Meeting-III , Davos, Swaziland, p.104.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={The potential use of TRAIL and its receptor expression profile as markers to monitor the prognosis of patients with rheumatoid arthritis}, congress name={World Immune Regulation Meeting-III}, city={Davos}, country={Swaziland}, year={2009}, pages={104} }